
2026-10-15
Ca hydroxyapatite is a biocompatible calcium phosphate compound widely utilized in medical aesthetics and regenerative medicine for bone grafting, dental restoration, and skin rejuvenation. As a premier supplier, Jinan Meiyi Biotechnology Co., Ltd. provides high-purity, synthetic ca hydroxyapatite tailored for cosmetic formulations and clinical applications. Our strategic sourcing model ensures rigorous quality control, regulatory compliance, and competitive wholesale pricing for B2B clients, including CDMOs, R&D laboratories, and aesthetic clinics globally.
Calcium hydroxyapatite, often abbreviated as CaHA or HAp, is a naturally occurring mineral form of calcium apatite. Its chemical formula is typically represented as Ca10(PO4)6(OH)2. This compound constitutes the primary inorganic component of human bone and tooth enamel, making it exceptionally biocompatible and bioactive.
In industrial and medical contexts, synthetic ca hydroxyapatite is engineered to mimic the structural and functional properties of natural bone mineral. Unlike generic calcium supplements, high-grade CaHA used in biomedical applications possesses a specific crystalline structure that facilitates osteoconduction—the process by which bone growth occurs along the surface of the material.
The efficacy of ca hydroxyapatite in various applications depends heavily on its physicochemical characteristics. Understanding these parameters is crucial for formulators and procurement specialists:
The versatility of ca hydroxyapatite has expanded its use beyond traditional orthopedics into the rapidly growing fields of cosmetic dermatology and regenerative aesthetics. Jinan Meiyi Biotechnology supports clients across these diverse sectors by supplying materials that meet specific application requirements.
In medical aesthetics, CaHA is a key active ingredient in non-surgical facial volumizers. When injected into the dermis, micro-particles of ca hydroxyapatite serve two primary functions:
For manufacturers of dermal fillers, the consistency and spherical uniformity of the CaHA particles are critical. Irregular particles can lead to uneven distribution or nodularity. Jinan Meiyi Biotechnology sources CaHA from certified manufacturers who specialize in producing monodisperse microspheres, ensuring smooth injection and predictable clinical outcomes.
Orthopedic and dental applications remain the largest volume drivers for ca hydroxyapatite. Due to its osteoconductive properties, it is used as a bone void filler in spinal fusion, trauma surgery, and dental implant procedures.
In dental regeneration, CaHA coatings on titanium implants enhance osseointegration, reducing healing time and improving implant stability. The material’s porosity allows vascularization and bone cell migration, facilitating seamless integration with host tissue.
Recent advancements in nanotechnology have enabled the use of nano-hydroxyapatite as a carrier for targeted drug delivery. Its high surface area and adsorption capacity allow it to bind therapeutic agents, such as antibiotics or anticancer drugs, releasing them in a controlled manner at the target site.
Jinan Meiyi Biotechnology Co., Ltd., headquartered in Jinan, Shandong Province, operates as a specialized subsidiary of Pacific Kangtai Scientific Instruments (Jinan) Co., Ltd. We are not merely a distributor; we are a strategic enabler for innovation in the bioactive technology sector. Our business model is built on scientific rigor, market responsiveness, and an unwavering commitment to quality assurance.
It is important to clarify our operational model: Jinan Meiyi Biotechnology does not engage in direct manufacturing. Instead, we function as a high-level strategic sourcing and quality-assured distribution partner. This distinction is vital for our clients because it allows us to remain agile and objective in selecting the best possible materials for their needs.
We leverage a well-established global supply chain network, maintaining long-term cooperative relationships with internationally recognized suppliers. These partners adhere to strict quality management systems, including ISO certifications and Good Manufacturing Practices (GMP). Our role involves:
Our team possesses deep specialization in bioactive technology applications within cosmetics and medical aesthetics. Unlike general chemical traders, our scientifically trained team stays at the forefront of international research. We understand the nuances of formulation development, such as the interaction between CaHA particles and cross-linked hyaluronic acid carriers.
This expertise enables us to offer more than just products; we provide technical consultation and regulatory intelligence sharing. Whether you are an R&D laboratory developing a new dermal filler formula or a CDMO scaling up production, we act as a knowledge-driven bridge between upstream innovation and downstream application.

Selecting the right grade of ca hydroxyapatite is critical for product performance. Below is a comparative overview of common specifications available through our network, tailored for different industrial needs.
| Parameter | Cosmetic Grade (Microspheres) | Medical/Implant Grade (Porous Granules) | Nano-Grade (Research/Drug Delivery) |
|---|---|---|---|
| Particle Size | 25–45 µm (Spherical) | 0.5–2 mm (Irregular/Porous) | < 100 nm |
| Purity | > 99.5% | > 98% | > 99% |
| Crystallinity | High | Moderate to High | Low to Moderate |
| Sterility | Sterile (Gamma/E-beam) | Sterile or Aseptic Processing | Non-sterile (typically) |
| Primary Application | Dermal Fillers, Skin Boosters | Bone Grafts, Dental Implants | Topical Skincare, Drug Carriers |
| Regulatory Focus | Biocompatibility, Endotoxin-free | Osteoconductivity, Resorption Rate | Surface Charge, Dispersion Stability |
When sourcing ca hydroxyapatite, buyers should prioritize three core metrics:
While hydroxyapatite exists in nature (e.g., bovine bone), synthetic ca hydroxyapatite is preferred in modern medical and cosmetic applications for several reasons:
For B2B buyers, securing a reliable supply of high-purity ca hydroxyapatite at competitive wholesale prices is a strategic imperative. Jinan Meiyi Biotechnology optimizes this process through our integrated supply chain model.
By leveraging long-term partnerships with certified manufacturers, we negotiate favorable terms that translate into competitive wholesale pricing for our clients. Our volume consolidation capabilities allow smaller R&D firms and mid-sized clinics to access premium-grade materials that might otherwise be cost-prohibitive.
We maintain strict control over storage conditions and shipping protocols. CaHA materials, particularly sterile grades, require careful handling to prevent moisture absorption or contamination. Our logistics framework ensures product integrity from origin to end-user, with real-time tracking and temperature-controlled options where necessary.
Navigating the regulatory landscape for medical devices and cosmetic ingredients is complex. Jinan Meiyi Biotechnology assists clients by providing comprehensive documentation packages. This includes detailed CoAs, stability data, and information on raw material origin, which are crucial for FDA, CE, or NMPA submissions.
Yes, synthetic ca hydroxyapatite is widely recognized as safe for injection when used in approved medical devices. It is biocompatible, biodegradable, and has a long history of clinical use in dentistry and orthopedics. In aesthetics, it is FDA-approved for certain indications. However, safety depends on the purity of the material and the sterility of the final formulation.
Hydroxyapatite is a specific type of calcium phosphate. While all hydroxyapatite is calcium phosphate, not all calcium phosphates are hydroxyapatite. Other forms include tricalcium phosphate (TCP) and amorphous calcium phosphate (ACP). CaHA is the most stable and least soluble form, making it ideal for long-term structural applications.
As a strategic sourcing partner, we can facilitate requests for specific particle size distributions. By working directly with our manufacturing partners, we can source ca hydroxyapatite that meets custom specifications for niche R&D projects or specialized formulations.
CaHA powder should be stored in a cool, dry place in airtight containers to prevent moisture absorption. For sterile grades, original packaging should remain sealed until use. Exposure to high humidity can affect flowability and potentially impact downstream processing.
No. Jinan Meiyi Biotechnology focuses on R&D support, strategic sourcing, and quality-assured distribution. We partner with certified manufacturers who specialize in the synthesis of high-purity bioactive materials. This model allows us to offer a broader range of verified products and maintain objectivity in quality control.

Calcium hydroxyapatite remains a cornerstone material in the advancement of medical aesthetics and regenerative medicine. Its unique combination of biocompatibility, osteoconductivity, and collagen-stimulating properties makes it indispensable for modern healthcare solutions. However, the quality of the final product is only as good as the raw materials used.
Jinan Meiyi Biotechnology Co., Ltd. stands as a trusted partner for businesses seeking high-purity ca hydroxyapatite. Through our rigorous supplier qualification, comprehensive quality assurance, and deep technical expertise, we enable our clients to innovate with confidence. Whether you are developing next-generation dermal fillers, advanced bone grafts, or novel skincare formulations, our strategic sourcing model ensures you receive materials that meet the highest international standards.
We invite R&D directors, procurement managers, and clinic owners to leverage our global network and technical insights. By choosing Jinan Meiyi Biotechnology, you gain more than a supplier; you gain a partner dedicated to the scientific integrity and commercial success of your projects.
Ready to source high-purity Ca Hydroxyapatite? Contact our technical team today to request a Certificate of Analysis, discuss wholesale pricing, or explore custom sourcing options for your specific application needs.